Funds and ETFs China Resources Double-Crane Pharmaceutical Co.,Ltd.

Equities

600062

CNE000000Q94

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
21.2 CNY -0.84% Intraday chart for China Resources Double-Crane Pharmaceutical Co.,Ltd. +0.66% +13.98%

ETFs positioned on China Resources Double-Crane Pharmaceutical Co.,Ltd.

Name Weight AuM 1st Jan change Investor Rating
0.00% 31 M€ +3.50% -
0.00% 34 M€ +2.14% -
CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the development, manufacture and distribution of pharmaceuticals. The Company's main businesses are classified into three segments: Chronic Disease segment, Specialist segment and Infusion segment. Chronic Disease segment mainly provides products for lowering blood pressure, blood fat and blood glucose. Specialist segment mainly involves in the research, development and distribution of pharmaceuticals targeting six areas, including cardiovascular and cerebrovascular, pediatrics, kidney disease, mental/nerve, anesthesia and analgesia and respiratory areas. Infusion segment various types of infusion products, such as basic infusion, therapeutic infusion and nutritional. The Company distributes its products mainly in domestic market.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
21.2 CNY
Average target price
24.91 CNY
Spread / Average Target
+17.52%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600062 Stock
  4. Funds and ETFs China Resources Double-Crane Pharmaceutical Co.,Ltd.